How They Differ

For people living with chronic or complex health conditions, patient assistance programs can help reduce the financial barriers to treatment. But the term patient assistance program (PAP) is often used broadly, which can make different types of assistance sound the same.

In reality, there is an important distinction between manufacturer PAPs and independent charitable patient assistance foundations. Manufacturer PAPs are sponsored by pharmaceutical companies and are typically tied to that company’s products. Charitable foundations operate independently and may support eligible patients across a disease area through assistance with costs such as copays, premiums, deductibles, and other eligible expenses.

That independence is a key difference—and one that can give charitable foundations a broader, patient-focused role in helping people access and stay on treatment.

How a Manufacturer Patient Assistance Program Works

A manufacturer patient assistance program (PAP) is created or funded by a pharmaceutical or biotechnology company to help qualifying patients access medications made by that company. Support may include no-cost medication or other forms of product-specific assistance.

What Makes a Charitable Patient Assistance Foundation Different

A charitable patient assistance foundation is an independent nonprofit that helps eligible patients manage healthcare expenses that can make treatment difficult to afford. Support may include costs such as copays, coinsurance, deductibles, insurance premiums, and other qualifying expenses.

Because these foundations operate independently from pharmaceutical manufacturers, their programs can be structured around the needs of people living with specific conditions rather than a single company’s product. Accessia Health helps eligible people with rare and chronic conditions address financial barriers and access needed care through its available patient programs.

Patient Assistance Foundations and Manufacturer PAPs Serve Different Roles

Although both types of programs are intended to help patients overcome barriers to treatment, their structures and roles are different.

1. Organizational independence and Patient-Centered Support 

One of the most significant differences is who operates the program and what its assistance is built around.

An independent charitable patient assistance foundation is a nonprofit organization that operates separately from pharmaceutical manufacturers. Its programs are guided by the foundation’s charitable mission, eligibility criteria, and disease-specific program guidelines.

In contrast, a manufacturer PAP, is created or sponsored by the company that makes the medication associated with the program and generally supports access to that company’s products.

For patients and healthcare professionals, this distinction provides clarity: an independent foundation’s role is to help eligible people overcome financial barriers related to a particular condition, rather than to promote or facilitate access to a specific manufacturer’s medication.

2. A broader focus on the patient’s healthcare needs

Manufacturer PAPs are generally centered on access to a manufacturer’s own medication or portfolio of medications.

Independent charitable foundations can take a different approach. Their programs may help individuals manage healthcare expenses associated with a particular disease or condition, subject to the requirements of the applicable fund.

This disease-focused approach can provide patients with support that reflects the broader financial realities of managing a chronic or complex condition—not simply the cost of obtaining one medication.

3. Independent eligibility and assistance decisions

Both charitable foundations and manufacturer PAPs establish eligibility requirements, but those requirements are set and administered by different organizations.

A manufacturer determines the criteria for its own patient assistance program.

An independent charitable foundation establishes and administers its own eligibility criteria and assistance processes. Depending on the program, eligibility may take into account factors such as diagnosis, insurance status, household income, residency, and the requirements of a specific disease fund.

This independent administration is an important feature of the charitable foundation model because decisions about assistance remain within the charitable organization itself.

4. Support can extend beyond a single treatment cost

The financial burden of a chronic or rare disease often goes beyond the price of one prescription. Insurance premiums, coinsurance, deductibles, and other healthcare-related expenses can all affect a patient’s ability to remain in treatment.

Independent charitable foundations may be able to address multiple types of eligible expenses, depending on the specific program. This can make charitable assistance an important part of helping patients maintain access to care over time.

Where Accessia Health Fits

For more than three decades, Accessia Health has worked to improve access to care for people living with rare or chronic health conditions. Through its patient programs, Accessia Health helps eligible individuals address financial barriers that can make it harder to begin or continue treatment.

We recognize that the challenges of living with a chronic or rare condition can extend beyond a single prescription or medical bill. Accessia Health’s patient-centered approach is designed around helping people overcome barriers that can interfere with access to and continuity of care.

As an independent nonprofit organization, Accessia Health administers its charitable programs separately from pharmaceutical manufacturers. That independence allows the organization to remain focused on its mission and on the needs of the patients and communities it serves.

Finding the Right Type of Patient Assistance

Understanding the difference between manufacturer PAPs and independent charitable foundations can make it easier to know where to turn for help.

Manufacturer PAPs may provide access to a manufacturer’s specific therapies, while independent charitable foundations can offer disease-specific assistance that is administered separately from any individual manufacturer.

For patients, caregivers, and healthcare professionals, the next step is simple: explore Accessia Health’s available patient programs to learn about current assistance options, eligibility requirements, and how to apply.

→ Start My Application